Literature DB >> 6870318

Effect of anatomical location on prognosis in patients with clinical stage I melanoma.

G S Rogers, A W Kopf, D S Rigel, R J Friedman, J L Levine, M Levenstein, R S Bart, M M Mintzis.   

Abstract

A study of the influence of the anatomical location of malignant melanoma on the prognosis of 971 patients with stage I disease disclosed specific high-, intermediate-, and low-risk sites. High-risk sites included scalp, mandibular area, midline of trunk (anterior and posterior), upper medial thighs, hands, feet (except the arches), popliteal fossae, and genitalia. The life-table-adjusted five-year disease-free survival was 54% in the high-risk locations, 79% in intermediate-risk locations, and 93% in low-risk sites. A Cox proportional hazards analysis demonstrated that the grouping of lesions by their anatomical risk location had prognostic value that was significant in a model of eight other known predictive variables (thickness, sex, age, type, level, mitotic index, ulceration, and presence of preexistent nevus). The results indicate that anatomical location of the primary melanoma is significantly associated with five-year disease-free survival.

Entities:  

Mesh:

Year:  1983        PMID: 6870318

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  8 in total

1.  At least one centimetre for each millimetre.

Authors:  F H Rampen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

2.  The incidental malignant melanoma.

Authors:  R H Griffiths; J C Briggs
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

3.  Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method.

Authors:  Y Umebayashi; F Otsuka
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.

Authors:  K Søndergaard; G Schou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

5.  Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.

Authors:  K Søndergaard; G Schou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

6.  Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years).

Authors:  Robin Reschke; Konstantin Dumann; Mirjana Ziemer
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.964

7.  Melanoma in buckinghamshire: data from the inception of the skin cancer multidisciplinary team.

Authors:  J J Cubitt; A A Khan; E Royston; M Rughani; M R Middleton; P G Budny
Journal:  J Skin Cancer       Date:  2013-09-16

8.  Malignant melanoma in Chile: different site distribution between private and state patients.

Authors:  Viviana B Zemelman; Carlos Y Valenzuela; Ivo Sazunic; Irene Araya
Journal:  Biol Res       Date:  2014       Impact factor: 5.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.